These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2224157)

  • 1. Genetically engineered and affinity purified plasma proteins.
    Meulien P; Tuddenham EG
    Baillieres Clin Haematol; 1990 Apr; 3(2):451-77. PubMed ID: 2224157
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant plasma proteins.
    Burnouf T
    Vox Sang; 2011 Jan; 100(1):68-83. PubMed ID: 21175657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies and genetically engineered related molecules: production and purification.
    Roque AC; Lowe CR; Taipa MA
    Biotechnol Prog; 2004; 20(3):639-54. PubMed ID: 15176864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affinity chromatography in the industrial purification of plasma proteins for therapeutic use.
    Burnouf T; Radosevich M
    J Biochem Biophys Methods; 2001 Oct; 49(1-3):575-86. PubMed ID: 11694303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of plasma derivatives.
    Mertens K
    Transfus Clin Biol; 2001 Jun; 8(3):303-5. PubMed ID: 11499982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical importance of human plasma proteins and their future development].
    Schwick HG
    Beitr Infusionsther; 1991; 28():115-23. PubMed ID: 1725608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of human therapeutic proteins in transgenic animals.
    Hoyer LW; Drohan WN; Lubon H
    Vox Sang; 1994; 67 Suppl 3():217-20. PubMed ID: 7975496
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic use of hemoderivatives].
    Yurrebaso Eguilior N; Mota Villaplana FM; Montoro Ronsano JB
    Sangre (Barc); 1997 Oct; 42(5):423-7. PubMed ID: 9424747
    [No Abstract]   [Full Text] [Related]  

  • 9. [Purification of recombinant lysostaphin by monoclonal antibody affinity chromatography].
    Huang J; Wu H; Zhang J; Huang Q
    Sheng Wu Gong Cheng Xue Bao; 2009 Jan; 25(1):147-51. PubMed ID: 19441240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and manufacture of monoclonal antibodies for radioimmunotherapy.
    Hale G; Berrie E; Bird P
    Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):258-66. PubMed ID: 15640789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of six human vitamin K-dependent proteins in a single chromatographic step using immunoaffinity columns.
    Jenny R; Church W; Odegaard B; Litwiller R; Mann K
    Prep Biochem; 1986; 16(3):227-45. PubMed ID: 3748998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A Method for the Parallel and Sequential Generation of Single-Domain Antibodies for the Proteomic Analysis of Human Blood Plasma].
    Goryainova OS; Ivanova TI; Rutovskaya MV; Tillib SV
    Mol Biol (Mosk); 2017; 51(6):985-996. PubMed ID: 29271962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternatives to human blood and blood resources.
    Prowse CV
    Vox Sang; 1998; 74 Suppl 2():21-8. PubMed ID: 9704423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of IgG Monoclonals with Engineered Immune Effector Functions.
    Vazquez-Lombardi R; Nevoltris D; Rouet R; Christ D
    Methods Mol Biol; 2018; 1827():313-334. PubMed ID: 30196504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein Engineering Allows for Mild Affinity-based Elution of Therapeutic Antibodies.
    Kanje S; VenskutonytÄ— R; Scheffel J; Nilvebrant J; Lindkvist-Petersson K; Hober S
    J Mol Biol; 2018 Sep; 430(18 Pt B):3427-3438. PubMed ID: 29886013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic plasma proteins--application of proteomics in process optimization, validation, and analysis of the final product.
    Gaso-Sokac D; Kovac S; Clifton J; Josic D
    Electrophoresis; 2011 May; 32(10):1104-17. PubMed ID: 21544836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of genetically engineered monoclonal antibodies for human immunotherapy.
    Parren PW
    Hum Antibodies Hybridomas; 1992 Jul; 3(3):137-45. PubMed ID: 1391663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of recombinant human anti-HAV monoclonal antibody.
    Wei JS; Tao R; Sun WW; Jia Q; Li C; Liang MF
    Sheng Wu Gong Cheng Xue Bao; 2004 Mar; 20(2):257-61. PubMed ID: 15969118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and serological analyses of tospoviral nucleocapsid proteins expressed by Zucchini yellow mosaic virus vector in squash.
    Chen TC; Hsu HT; Jain RK; Huang CW; Lin CH; Liu FL; Yeh SD
    J Virol Methods; 2005 Nov; 129(2):113-24. PubMed ID: 15992936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin K-dependent protein production in transgenic animals.
    Luboń H; Paleyanda RK
    Thromb Haemost; 1997 Jul; 78(1):532-6. PubMed ID: 9198210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.